Puressentiel   Report issue

For profit
Founded: London United Kingdom (2005)
Status: No NME R&D (2005)

Organization Overview

First Clinical Trial
2019
NCT03963076
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Puressentiel

Active Ingredients

Drugs in Other Trials (1)

sea water (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1